C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

TG Therapeutics Announces FDA Approval of BRIUMVI™ (ublituximab-xiiy)

Wednesday, December 28, 2022

TG Therapeutics Inc today announced theUS Food and Drug AdministrationFDA has approved BRIUMVI ublituximabxiiy for the treatment of relapsing forms of multiple sclerosis RMS to include clinically isolated syndrome relapsingremitting disease and activ...

Acer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVA for Patients with Urea Cycle Disorders

Tuesday, December 27, 2022

Acer Therapeutics Inc and its collaboration partner RELIEF THERAPEUTICS Holding SA today announced that the US Food and Drug Administration FDA has approved OLPRUVA sodium phenylbutyrate for oral suspension in the US for the treatment of certain pati...

Antengene Enters into a Global Clinical Collaboration with MSD to Evaluate ATG-037 (CD73 Inhibitor) in Combination with KEYTRUDA® (pembrolizumab)

Tuesday, December 27, 2022

Antengene Corporation Limited a leading commercialstage innovative global biopharmaceutical company dedicated to discovering developing and commercializing firstinclass andor bestinclass medicines for hematology and oncology today announced it has en...

Nova Mentis Receives Health Canada Approval for First-of-its-Kind Psilocybin Clinical Trial

Thursday, December 22, 2022

Nova Mentis Life Science Corp a biotechnology company and global leader in firstinclass psilocybinbased therapeutics and complementary diagnostics for neuroinflammatory disorders is proud to announce that the company has received a No Objection Lette...

Mersana Therapeutics Announces Research Collaboration and Commercial License Agreement with Merck KGaA, Darmstadt, Germany to Develop Novel Immunosynthen Antibody-Drug Conjugates

Thursday, December 22, 2022

Mersana Therapeutics Inc a clinicalstage biopharmaceutical company focused on discovering and developing a pipeline of antibodydrug conjugates ADCs targeting cancers in areas of high unmet medical need today announced a research collaboration and com...

Hataali and Reef Group announce strategic partnership for ATMP Smart Labs

Thursday, December 22, 2022

Hataali the award winning leader in digital data solution platforms for advanced therapies announces a strategic partnership with Reef Group a real estate company specialising in the knowledge sectors and GmPGxP compliant clean rooms for the pharma...

InflaRx Announces Amendment of Co-Development Agreement and Additional Equity Investment by Staidson in Connection with Regulatory Filing in China

Wednesday, December 21, 2022

InflaRxNV a clinicalstage biopharmaceutical company developing antiinflammatory therapeutics by targeting the complement system today announced that the Company has amended its existing codevelopment agreement with Staidson Beijing BioPharmaceuticals...

ORIC Pharmaceuticals Announces Clinical Development Collaboration with Pfizer for ORIC-533 in Multiple Myeloma and Concurrent $25 Million Equity Investment by Pfizer

Wednesday, December 21, 2022

ORIC Pharmaceuticals Inc a clinicalstage oncology company focused on developing treatments that address mechanisms of therapeutic resistance today announced that it has entered into a clinical development collaboration for a potential Phase study of...

Astellas, Eisai, Daiichi Sankyo and Takeda Agree to Collaborate to Reduce Environmental Burden in the Field of Pharmaceutical Packaging

Wednesday, December 21, 2022

Astellas Pharma Inc Eisai Co Ltd Daiichi Sankyo Company Limited and Takeda Pharmaceutical Company Limited today announced that the four companies have agreed the collaboration to reduce environmental burden in the field of pharmaceutical packaging

POINT Biopharma Announces Closing of Agreements with Lantheus Holdings

Tuesday, December 20, 2022

POINT Biopharma Global Inc a company accelerating the discovery development and global access to lifechanging radiopharmaceuticals today announced that the closing conditions including HartScottRodino antitrust clearance have been met for the previou...